BioGaia AB (BIOGY)
11.50
-0.58
(-4.80%)
USD |
OTCM |
Jun 28, 16:00
BioGaia Price to Book Value: 5.706 for June 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
June 28, 2024 | 5.706 |
June 27, 2024 | 5.994 |
June 26, 2024 | 5.994 |
June 21, 2024 | 5.994 |
June 20, 2024 | 5.994 |
June 18, 2024 | 5.994 |
June 17, 2024 | 5.994 |
June 14, 2024 | 5.994 |
June 13, 2024 | 5.994 |
June 12, 2024 | 5.994 |
June 11, 2024 | 5.994 |
June 10, 2024 | 5.994 |
June 07, 2024 | 5.994 |
June 06, 2024 | 5.994 |
June 05, 2024 | 5.994 |
June 04, 2024 | 5.994 |
June 03, 2024 | 5.994 |
May 31, 2024 | 5.994 |
May 30, 2024 | 5.994 |
May 29, 2024 | 5.820 |
May 28, 2024 | 5.820 |
May 24, 2024 | 5.706 |
May 23, 2024 | 5.706 |
May 22, 2024 | 5.706 |
May 21, 2024 | 5.706 |
Date | Value |
---|---|
May 20, 2024 | 5.706 |
May 17, 2024 | 5.706 |
May 16, 2024 | 5.706 |
May 15, 2024 | 5.706 |
May 14, 2024 | 5.706 |
May 13, 2024 | 5.706 |
May 10, 2024 | 5.706 |
May 09, 2024 | 5.706 |
May 08, 2024 | 5.706 |
May 07, 2024 | 5.706 |
May 06, 2024 | 4.823 |
May 03, 2024 | 4.823 |
May 02, 2024 | 4.823 |
May 01, 2024 | 4.823 |
April 30, 2024 | 4.823 |
April 29, 2024 | 4.823 |
April 26, 2024 | 4.823 |
April 25, 2024 | 4.823 |
April 24, 2024 | 4.823 |
April 23, 2024 | 4.823 |
April 22, 2024 | 4.823 |
April 19, 2024 | 4.823 |
April 18, 2024 | 4.823 |
April 17, 2024 | 5.999 |
April 16, 2024 | 5.999 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.446
Minimum
May 18 2022
19.96
Maximum
Dec 18 2020
7.548
Average
5.360
Median
Nov 23 2021
Price to Book Value Benchmarks
Abliva AB | 2.719 |
Karolinska Development AB | 0.5938 |
Calliditas Therapeutics AB | 92.80 |
Oncopeptides AB | 1.961 |
Olink Holding AB | 6.863 |
Price to Book Value Related Metrics
PE Ratio | 32.90 |
PS Ratio | 9.43 |
Price to Free Cash Flow | 38.10 |
Price | 11.50 |
Earnings Yield | 3.04% |
Market Cap | 1.161B |
Operating PE Ratio | 28.09 |
Normalized PE Ratio | 32.90 |